Translating scientific knowledge into innovative solutions is key for societal progress and to bring our vision “Health for All, Hunger for None” to life. No one can leverage the full potential of these solutions alone – partnerships play a key role. That’s why we are working with both scientists and scientific institutions around the world to find new and sustainable solutions in health and agriculture.
While collaborations are essential, partnerships between the public and private sector are seen by some with skepticism and a plea for more transparency has been made. With our new Bayer Science Collaboration Explorer, we want to address this concern and have started publishing information related to our scientific collaborations with external partners.
With the publicly accessible Bayer Science Collaboration Explorer, we invite you to discover our scientific collaborations using the database below where we disclose information on newly established contracts with universities, public research institutions, and individuals. The Explorer currently includes information about 300+ collaborations and will grow over time. In spring 2022, the Explorer was successfully audited by Deloitte (view audit report). The Explorer was initially rolled-out in Germany in September 2021. Since December 2022, the Explorer discloses contract-based research collaborations also in the United States, with the ambition to include additional countries in the future. Have a look yourself!
The Bayer Science Collaboration Explorer started with contract-based research collaborations in Germany in September 2021 and has extended its scope to the United States in December 2022. The disclosed partner types are universities, public research institutions, and individuals. The scope of the Bayer Science Collaboration Explorer will be extended stepwise.
Please find here a detailed definition of the in-scope partner types:
Commercial businesses and Healthcare Professionals (HCPs) are currently excluded; however, collaborations with HCPs are covered by Bayer’s “Transfer of Value” initiative and therefore not duplicated here.
Balancing the transparency requirements of the public with confidentiality needs of Bayer and our partners, the following details are disclosed for each collaboration listed above:
You have questions about our science collaborations?